These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18475972)

  • 1. Knigth's Move in the Periodic Table, From Copper to Platinum, Novel Antitumor Mixed Chelate Copper Compounds, Casiopeinas, Evaluated by an in Vitro Human and Murine Cancer Cell Line Panel.
    Gracia-Mora I; Ruiz-Ramírez L; Gómez-Ruiz C; Tinoco-Méndez M; Márquez-Quiñones A; Lira LR; Marín-Hernández A; Macías-Rosales L; Bravo-Gómez ME
    Met Based Drugs; 2001; 8(1):19-28. PubMed ID: 18475972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the DNA interaction of copper compounds belonging to the Casiopeínas® antitumoral series.
    Becco L; García-Ramos JC; Azuara LR; Gambino D; Garat B
    Biol Trace Elem Res; 2014 Nov; 161(2):210-5. PubMed ID: 25119709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. π-Stacking between Casiopeinas® and DNA bases.
    Galindo-Murillo R; Hernandez-Lima J; González-Rendón M; Cortés-Guzmán F; Ruíz-Azuara L; Moreno-Esparza R
    Phys Chem Chem Phys; 2011 Aug; 13(32):14510-5. PubMed ID: 21748173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative activity and QSAR study of copper(II) mixed chelate [Cu(N-N)(acetylacetonato)]NO3 and [Cu(N-N)(glycinato)]NO3 complexes, (Casiopeínas).
    Bravo-Gómez ME; García-Ramos JC; Gracia-Mora I; Ruiz-Azuara L
    J Inorg Biochem; 2009 Feb; 103(2):299-309. PubMed ID: 19027166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the binding of four anti-tumor Casiopeínas® to human serum albumin.
    Correia I; Borovic S; Cavaco I; Matos CP; Roy S; Santos HM; Fernandes L; Capelo JL; Ruiz-Azuara L; Pessoa JC
    J Inorg Biochem; 2017 Oct; 175():284-297. PubMed ID: 28806645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical determination of half-wave potentials for phenanthroline-, bipyridine-, acetylacetonate-, and glycinate-containing copper (II) complexes.
    Valdéz-Camacho JR; Ramírez-Solís A; Escalante J; Ruiz-Azuara L; Hô M
    J Mol Model; 2020 Jul; 26(7):191. PubMed ID: 32617735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and hematotoxicity of a novel copper-based anticancer agent: casiopeina III-Ea, after a single intravenous dose in rats.
    Vértiz G; García-Ortuño LE; Bernal JP; Bravo-Gómez ME; Lounejeva E; Huerta A; Ruiz-Azuara L
    Fundam Clin Pharmacol; 2014 Feb; 28(1):78-87. PubMed ID: 22958076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitochondrial apoptotic pathway is induced by Cu(II) antineoplastic compounds (Casiopeínas
    García-Ramos JC; Gutiérrez AG; Vázquez-Aguirre A; Toledano-Magaña Y; Alonso-Sáenz AL; Gómez-Vidales V; Flores-Alamo M; Mejía C; Ruiz-Azuara L
    Biometals; 2017 Feb; 30(1):43-58. PubMed ID: 27988860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-212.
    Gutiérrez AG; Vázquez-Aguirre A; García-Ramos JC; Flores-Alamo M; Hernández-Lemus E; Ruiz-Azuara L; Mejía C
    J Inorg Biochem; 2013 Sep; 126():17-25. PubMed ID: 23727332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA, a target of mixed chelate copper(II) compounds (Casiopeinas®) studied by electrophoresis, UV-vis and circular dichroism techniques.
    Figueroa-DePaz Y; Resendiz-Acevedo K; Dávila-Manzanilla SG; García-Ramos JC; Ortiz-Frade L; Serment-Guerrero J; Ruiz-Azuara L
    J Inorg Biochem; 2022 Jun; 231():111772. PubMed ID: 35279445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of acute respiratory and cardiovascular toxicity of casiopeinas in anaesthetized dogs.
    Leal-García M; García-Ortuño L; Ruiz-Azuara L; Gracia-Mora I; Luna-Delvillar J; Sumano H
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):151-8. PubMed ID: 17697033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclo-tetravanadate bridged copper complexes as potential double bullet pro-metallodrugs for cancer treatment.
    Martínez-Valencia B; Corona-Motolinia ND; Sánchez-Lara E; Noriega L; Sánchez-Gaytán BL; Castro ME; Meléndez-Bustamante F; González-Vergara E
    J Inorg Biochem; 2020 Jul; 208():111081. PubMed ID: 32531543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casiopeinas® third generation, with indomethacin: synthesis, characterization, DFT studies, antiproliferative activity, and nanoencapsulation.
    Godínez-Loyola Y; Gracia-Mora J; Rojas-Montoya ID; Hernández-Ayala LF; Reina M; Ortiz-Frade LA; Rascón-Valenzuela LA; Robles-Zepeda RE; Gómez-Vidales V; Bernad-Bernad MJ; Ruiz-Azuara L
    RSC Adv; 2022 Jul; 12(33):21662-21673. PubMed ID: 35975050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New achievements on biological aspects of copper complexes Casiopeínas®: interaction with DNA and proteins and anti-Trypanosoma cruzi activity.
    Becco L; Rodríguez A; Bravo ME; Prieto MJ; Ruiz-Azuara L; Garat B; Moreno V; Gambino D
    J Inorg Biochem; 2012 Apr; 109():49-56. PubMed ID: 22377716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
    Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
    J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
    Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
    Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The π-back-bonding modulation and its impact in the electronic properties of Cu(II) antineoplastic compounds: an experimental and theoretical study.
    García-Ramos JC; Galindo-Murillo R; Tovar-Tovar A; Alonso-Saenz AL; Gómez-Vidales V; Flores-Álamo M; Ortiz-Frade L; Cortes-Guzmán F; Moreno-Esparza R; Campero A; Ruiz-Azuara L
    Chemistry; 2014 Oct; 20(42):13730-41. PubMed ID: 25196088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
    Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
    J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxic assessment of the copper chelated compounds Casiopeinas: Clues about their mechanisms of action.
    Serment-Guerrero J; Bravo-Gomez ME; Lara-Rivera E; Ruiz-Azuara L
    J Inorg Biochem; 2017 Jan; 166():68-75. PubMed ID: 27838580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.
    Ramakrishnan S; Rajendiran V; Palaniandavar M; Periasamy VS; Srinag BS; Krishnamurthy H; Akbarsha MA
    Inorg Chem; 2009 Feb; 48(4):1309-22. PubMed ID: 19140687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.